| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.48 | 0.004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |